Log in to save to my catalogue

Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherap...

Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherap...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2617276625

Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching

About this item

Full title

Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching

Publisher

Singapore: Springer Singapore

Journal title

Esophagus : official journal of the Japan Esophageal Society, 2022-04, Vol.19 (2), p.224-232

Language

English

Formats

Publication information

Publisher

Singapore: Springer Singapore

More information

Scope and Contents

Contents

Objectives
This study aims to investigate the efficacy and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer.
Methods
We retrospectively identified patients who were treated with neoadjuvant immunotherapy and chemotherapy (NICT,
n
 = 27) or chemotherapy a...

Alternative Titles

Full title

Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2617276625

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2617276625

Other Identifiers

ISSN

1612-9059

E-ISSN

1612-9067

DOI

10.1007/s10388-021-00899-x

How to access this item